CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Background: Depression in older adults is common and is associated with poor quality of life, increased morbidity and early mortality, and increased health and social care use. Collaborative care, a low-intensity intervention for depression that is shown to be effective in working-age adults, has not yet been evaluated in older people with depression who are managed in UK primary care. The CollAborative care for Screen-Positive EldeRs (CASPER) plus trial fills the evidence gap identified by the most recent guidelines on depression management. Objectives: To establish the clinical effectiveness and cost-effectiveness of collaborative care for older adults with major depressive disorder in primary care. Design: A pragmatic, multicentred, two-arm, parallel, individually randomised controlled trial with embedded qualitative study. Participants were automatically randomised by computer, by the York Trials Unit Randomisation Service, on a 1 : 1 basis using simple unstratified randomisation after informed consent and baseline measures were collected. Blinding was not possible. Setting: Sixty-nine general practices in the north of England. Participants: A total of 485 participants aged ≥ 65 years with major depressive disorder. Interventions: A low-intensity intervention of collaborative care, including behavioural activation, delivered by a case manager for an average of six sessions over 7–8 weeks, alongside usual general practitioner (GP) care. The control arm received only usual GP care. Main outcome measures: The primary outcome measure was Patient Health Questionnaire-9 items score at 4 months post randomisation. Secondary outcome measures included depression severity and caseness at 12 and 18 months, the EuroQol-5 Dimensions, Short Form questionnaire-12 items, Patient Health Questionnaire-15 items, Generalised Anxiety Disorder-7 items, Connor–Davidson Resilience Scale-2 items, a medication questionnaire, objective data and adverse events. Participants were followed up at 12 and 18 months. Results: In total, 485 participants were randomised (collaborative care,n = 249; usual care,n = 236), with 390 participants (80%: collaborative care, 75%; usual care, 86%) followed up at 4 months, 358 participants (74%: collaborative care, 70%; usual care, 78%) followed up at 12 months and 344 participants (71%: collaborative care, 67%; usual care, 75%) followed up at 18 months. A total of 415 participants were included in primary analysis (collaborative care,n = 198; usual care,n = 217), which revealed a statistically significant effect in favour of collaborative care at the primary end point at 4 months [8.98 vs. 10.90 score points, mean difference 1.92 score points, 95% confidence interval (CI) 0.85 to 2.99 score points;p < 0.001], equivalent to a standard effect size of 0.34. However, treatment differences were not maintained in the longer term (at 12 months: 0.19 score points, 95% CI –0.92 to 1.29 score points;p = 0.741; at 18 months: < 0.01 score points, 95% CI –1.12 to 1.12 score points;p = 0.997). The study recorded details of all serious adverse events (SAEs), which consisted of ‘unscheduled hospitalisation’, ‘other medically important condition’ and ‘death’. No SAEs were related to the intervention. Collaborative care showed a small but non-significant increase in quality-adjusted life-years (QALYs) over the 18-month period, with a higher cost. Overall, the mean cost per incremental QALY for collaborative care compared with usual care was £26,016; however, for participants attending six or more sessions, collaborative care appears to represent better value for money (£9876/QALY). Limitations: Study limitations are identified at different stages: design (blinding unfeasible, potential contamination), process (relatively low overall consent rate, differential attrition/retention rates) and analysis (no baseline health-care resource cost or secondary/social care data). Conclusion: Collaborative care was effective for older people with case-level depression across a range of outcomes in the short term though the reduction in depression severity was not maintained over the longer term of 12 or 18 months. Participants who received six or more sessions of collaborative care did benefit substantially more than those who received fewer treatment sessions but this difference was not statistically significant. Future work recommendations: Recommendations for future research include investigating the longer-term effect of the intervention. Depression is a recurrent disorder and it would be useful to assess its impact on relapse and the prevention of future case-level depression. Trial registration: Current Controlled Trials ISRCTN45842879. Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 21, No. 67. See the NIHR Journals Library website for further project information.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: A New Depression Diagnostic and Severity Measure
Kroenke, K., & Spitzer, R. L. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020901-06 · Cited by 5,898
EuroQol: the current state of play
Brooks, R. (1996) · Health Policy · doi:10.1016/0168-8510(96)00822-6 · Cited by 5,815
Lecrubier, Y., Sheehan, D., Weiller, E., Amorim, P., Bonora, I., Sheehan, K. H., Janavs, J., & Dunbar, G. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)83296-8 · Cited by 3,513
Unützer, J., Katon, W., Callahan, C. M., Williams, Jr., Hunkeler, E., Harpole, L., Hoffing, M., Della Penna, R. D., Noël, P. H., Lin, E. H. B., et al. (2002) · JAMA · doi:10.1001/jama.288.22.2836 · Cited by 2,405
Sheehan, D., Lecrubier, Y., Harnett Sheehan, K., Janavs, J., Weiller, E., Keskiner, A., Schinka, J., Knapp, E., Sheehan, M., & Dunbar, G. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)83297-x · Cited by 2,149
Case-finding instruments for depression: Two questions are as good as many
Whooley, M. A., Avins, A. L., Miranda, J., & Browner, W. S. (1997) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1997.00076.x · Cited by 1,826
A component analysis of cognitive-behavioral treatment for depression.
Jacobson, N. S., Dobson, K. S., Truax, P. A., Addis, M. E., Koerner, K., Gollan, J. K., Gortner, E., & Prince, S. E. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.64.2.295 · Cited by 1,413
Collaborative Care for Depression: A Cumulative Meta-analysis and Review of Longer-term Outcomes
Gilbody, S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.21.2314 · Cited by 1,340
Collaborative care for depression and anxiety problems
Archer, J., Bower, P., Gilbody, S., Lovell, K., Richards, D., Gask, L., Dickens, C., & Coventry, P. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006525.pub2 · Cited by 1,126
Self-citationKaton (2004) · doi:10.1001/archpsyc.61.10.1042 · Cited by 737
Ekers, D., Webster, L., Van Straten, A., Cuijpers, P., Richards, D., & Gilbody, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100100 · Cited by 565
Self-citationWhat is behavioral activation?
Kanter, J. W., Manos, R. C., Bowe, W. M., Baruch, D. E., Busch, A. M., & Rusch, L. C. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.04.001 · Cited by 515
Bower, P., Gilbody, S., Richards, D., Fletcher, J., & Sutton, A. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.023655 · Cited by 429
Self-citationA meta-analysis of randomized trials of behavioural treatment of depression
Ekers, D., Richards, D., & Gilbody, S. (2008) · Psychological Medicine · doi:10.1017/s0033291707001614 · Cited by 400 · cited 3×
“36) Median score (minimum, maximum) 12 (2, 26) 11 (2, 24) 12 (2, 24) 11 (2, 24) SF-12 (PCS) n 245 234 198 217 Mean score (SD) 35.”
Self-citationCoventry, P., Lovell, K., Dickens, C., Bower, P., Chew-Graham, C., McElvenny, D., Hann, M., Cherrington, A., Garrett, C., Gibbons, C. J., et al. (2015) · BMJ · doi:10.1136/bmj.h638 · Cited by 325
Self-citationBurroughs, H. (2006) · Family Practice · doi:10.1093/fampra/cmi115 · Cited by 220
Lovell, K., & Richards, D. (2000) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465800004070 · Cited by 216
Self-citationCollaborative care for depression in UK primary care: a randomized controlled trial
Richards, D. A., Lovell, K., Gilbody, S., Gask, L., Torgerson, D., Barkham, M., Bland, M., Bower, P., Lankshear, A. J., Simpson, A., et al. (2008) · Psychological Medicine · doi:10.1017/s0033291707001365 · Cited by 165
Self-citationGilbody, S., Lewis, H., Adamson, J., Atherton, K., Bailey, D., Birtwistle, J., Bosanquet, K., Clare, E., Delgadillo, J., Ekers, D., et al. (2017) · JAMA · doi:10.1001/jama.2017.0130 · Cited by 126
Chew-Graham, C., Kovandžić, M., Gask, L., Burroughs, H., Clarke, P., Sanderson, H., & Dowrick, C. (2012) · Health & Social Care in the Community · doi:10.1111/j.1365-2524.2011.01015.x · Cited by 88 · cited 1×
“Supervisions One per week (12) 5 minutes 1 hour 88 1 hour over 12 weeks GP communication Three letters 30 minutes 1.”
BackgroundSelf-citationTreating depression in later life
Chew-Graham, C., Baldwin, R., & Burns, A. (2004) · BMJ · doi:10.1136/bmj.329.7459.181 · Cited by 62 · cited 8×
“80) Median score (minimum, maximum) 14 (3, 27) 14 (4, 27) 14 (3, 26) 14 (4, 27) PHQ-9 grouping, n (%) No depression 2 (0.”
BackgroundMethodInfluentialSelf-citationSamad, Z., Brealey, S., & Gilbody, S. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2680 · Cited by 57
Self-citationGreen, C., Richards, D. A., Hill, J. J., Gask, L., Lovell, K., Chew-Graham, C., Bower, P., Cape, J., Pilling, S., Araya, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104225 · Cited by 52 · cited 1×
“79) Median (minimum, maximum) 8 (0, 24) 11 (0, 26) 9 (0, 26) 12 months, n (%) 172 (69) 185 (78) 357 (74) Mean (SD) 10.”
Self-citationImproving access to psychological therapies and older people: Findings from the Eastern Region
Matthew Prina, A., Marioni, R. E., Hammond, G. C., Jones, P. B., Brayne, C., & Dening, T. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.03.008 · Cited by 37
Overend, K., Bosanquet, K., Bailey, D., Foster, D., Gascoyne, S., Lewis, H., Nutbrown, S., Woodhouse, R., Gilbody, S., & Chew-Graham, C. (2015) · BMC Family Practice · doi:10.1186/s12875-015-0362-2 · Cited by 30 · cited 1×
“96) Median (minimum, maximum) 71 (64, 98) 70 (65, 92) 70 (64, 88) 70 (65, 92) Sex, n (%) Male 98 (39.”
Self-citation
Cited by
Behavioural activation therapy for depression in adults
Uphoff, E., Ekers, D., Robertson, L., Dawson, S., Sanger, E., South, E., Samaan, Z., Richards, D., Meader, N., & Churchill, R. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013305.pub2 · Cited by 98
Krause, M., Gutsmiedl, K., Bighelli, I., Schneider-Thoma, J., Chaimani, A., & Leucht, S. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.07.130 · Cited by 65
Menear, M., Dugas, M., Careau, E., Chouinard, M.-C., Dogba, M. J., Gagnon, M.-P., Gervais, M., Gilbert, M., Houle, J., Kates, N., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.008 · Cited by 52
“In the CADET and CASPER Plus programs, authors specifically mentioned that patients were involved throughout the research process (Bosanquet et al., 2017; Richards et al., 2016).”
Background
Metadata
- Authors
- Bosanquet, K., Adamson, J., Atherton, K., Bailey, D., Baxter, C., Beresford-Dent, J., Birtwistle, J., Chew-Graham, C., Clare, E., Delgadillo, J., Ekers, D., Foster, D., Gabe, R., Gascoyne, S., Haley, L., Hamilton, J., Hargate, R., Hewitt, C., Holmes, J., Keding, A., Lewis, H., McMillan, D., Meer, S., Mitchell, N., Nutbrown, S., Overend, K., Parrott, S., Pervin, J., Richards, D. A., Spilsbury, K., Torgerson, D., Traviss-Turner, G., Trépel, D., Woodhouse, R., & Gilbody, S.
- Venue
- Health Technology Assessment
- Published
- 2017-11
- Volume
- 21
- Issue
- 67
- Pages
- 1-252
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2770588153
- Cited by
- 79
- References
- 25
- FWCI
- 17.28
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.